Journal
LIFE-BASEL
Volume 11, Issue 8, Pages -Publisher
MDPI
DOI: 10.3390/life11080737
Keywords
matrix Gla protein; coronary artery disease; vascular calcification; vitamin K
Categories
Ask authors/readers for more resources
MGP is considered an important inhibitor of vascular calcification, with its functionality depending on phosphorylation and carboxylation. Dysfunctional species of MGP, such as dephosphorylated-uncarboxylated MGP, may serve as biomarkers for microvascular health and play a role in clinical decision making regarding initiation of vitamin K supplementation.
Coronary artery disease (CAD) is widely recognized as one of the most important clinical entities. In recent years, a large body of accumulated data suggest that coronary artery calcification, a process highly prevalent in patients with CAD, occurs via well-organized biologic processes, rather than passively, as previously regarded. Matrix Gla protein (MGP), a vitamin K-dependent protein, emerged as an important inhibitor of both intimal and medial vascular calcification. The functionality of MGP hinges on two post-translational modifications: phosphorylation and carboxylation. Depending on the above-noted modifications, various species of MGP may exist in circulation, each with their respective level of functionality. Emerging data suggest that dysfunctional species of MGP, markedly, dephosphorylated-uncarboxylated MGP, might find its application as biomarkers of microvascular health, and assist in clinical decision making with regard to initiation of vitamin K supplementation. Hence, in this review we summarized the current knowledge with respect to the role of MGP in the complex network of vascular calcification with concurrent inferences to CAD. In addition, we discussed the effects of warfarin use on MGP functionality, with concomitant implications to coronary plaque stability.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available